MiRXES Pte Ltd

MiRXES Pte Ltd is a pioneering biotechnology company headquartered in Singapore, dedicated to transforming healthcare through early, actionable, and personalized diagnostics. With a mission to save lives, MiRXES leverages cutting-edge microRNA (miRNA) technology to develop innovative diagnostic solutions that enable early detection of diseases, particularly cancer, and improve patient outcomes. The company's expertise in miRNA-based diagnostics has positioned it as a leader in precision oncology and infectious disease testing, offering advanced tools and services that empower healthcare providers and researchers alike.

MiRXES is committed to advancing precision medicine by providing specialty testing services and research tools tailored to the needs of biopharma and life sciences industries. By integrating scientific innovation with practical applications, the company aims to bridge the gap between research and clinical practice, ensuring that patients benefit from timely and accurate diagnoses. MiRXES' global footprint and collaborative approach underscore its dedication to improving healthcare systems worldwide, making it a trusted partner in the fight against complex diseases.